Village Books & Paper Dreams - Fairhaven
Mon-Sat: 9am-8pm
Sun: 10am-8pm
masks required
 
Village Books - Lynden
Mon-Sat: 10am-6pm
Sun: 12-4pm
masks required

The Funding of Biopharmaceutical Research and Development (Hardcover)

The Funding of Biopharmaceutical Research and Development Cover Image
Email or call for price
Not in-stock currently- expect arrival in 1-14 business days
(This book cannot be returned.)

Description


The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers face a multitude of public and private funding options with respect to bringing their idea or innovation to market. These funding options are continually changing and complex, and are expected to decrease in the near future. A lack of understanding of the scale, scope, and inner workings of the funding aspects of R&D can, at times, act as a barrier for all involved, and can slow down or even eliminate the R&D process. The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in this market sector, both in the US and internationally. This includes a review and discussion of public-private partnership activity and their inner-workings, noting the complementary relationship between public and private funding. The book also contains an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It goes on to provide an outline of venture capital activity, detailing the methods by which venture capital firms raise capital and are organized, a description of the venture capital-entrepreneur arrangement, and the effects of this arrangement. The book also presents an overview of the IPO process and the various fates of firms going public.

About the Author


David R. Williams is Associate Professor of Health Care Management and Director of the Health Care Management Program at Appalachian State University, North Carolina. His research interests are in biopharmaceutical IPOs, economic amalgamation in healthcare and real option reasoning.


Product Details
ISBN: 9781907568947
ISBN-10: 1907568948
Publisher: Woodhead Publishing
Publication Date: October 31st, 2013
Pages: 284
Language: English
Series: Woodhead Publishing Series in Biomedicine